I agree that this site is using cookies. You can find further informations here.
X
Mototsugu Tanaka
294  results:
Search for persons X
?
1

Guidelines for clinical evaluation of chronic kidney diseas..:

Sugawara, Yuka ; Kanda, Eiichiro ; Hamano, Takayuki...
Clinical and Experimental Nephrology.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Postmarket safety communications on drugs approved in Japan..:

Tanaka, Yusuke ; Tanaka, Mototsugu ; Miyazawa, Haruna...
Clinical and Translational Science.  17 (2024)  4 - p. , 2024
Link: https://doi.org/10.1111/..
 
?
3

Conditional early approval for new drug applications in Jap..:

Tanaka, Mototsugu ; Miyazawa, Haruna ; Terashima, Ryohei.
Clinical and Translational Science.  16 (2023)  8 - p. 1289-1293 , 2023
Link: https://doi.org/10.1111/..
 
?
4

Aortic arch calcification affects causes of death in patien..:

Hashiba, Toyohiro ; Tanaka, Mototsugu ; Honda, Tomoko...
Renal Replacement Therapy.  8 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
5

Effluent N‐terminal expressed in renal cell carcinoma/mesot..:

Idei, Mayumi ; Abe, Masaaki ; Tanaka, Mototsugu...
Therapeutic Apheresis and Dialysis.  26 (2022)  5 - p. 1014-1022 , 2022
Link: https://doi.org/10.1111/..
 
?
6

Need for evidence on long-term prognosis of PD+HD: a commen..:

Tanaka, Mototsugu ; Mise, Naobumi
BMC Nephrology.  22 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
7

A bacterial small RNA regulates the adaptation of Helicobac..:

Kinoshita-Daitoku, Ryo ; Kiga, Kotaro ; Miyakoshi, Masatoshi...
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
8

Achievements and challenges of the Sakigake designation sys..:

Tanaka, Mototsugu ; Idei, Mayumi ; Sakaguchi, Hiroshi...
British Journal of Clinical Pharmacology.  87 (2021)  10 - p. 4027-4035 , 2021
Link: https://doi.org/10.1111/..
 
?
9

The PMDA Perspectives on New Oral Prolyl Hydroxylase Domain..:

Tanaka, Mototsugu ; Ikuma, Mutsuhiro ; Asakura, Wataru.
Clinical Pharmacology & Therapeutics.  111 (2021)  2 - p. 358-361 , 2021
Link: https://doi.org/10.1002/..
 
?
10

Rationales of delay and difference in regulatory review by ..:

Tanaka, Mototsugu ; Idei, Mayumi ; Sakaguchi, Hiroshi...
British Journal of Clinical Pharmacology.  87 (2021)  8 - p. 3279-3291 , 2021
Link: https://doi.org/10.1111/..
 
?
11

Hospitalization for Patients on Combination Therapy With Pe..:

Tanaka, Mototsugu ; Ishibashi, Yoshitaka ; Hamasaki, Yoshifumi...
Kidney International Reports.  5 (2020)  4 - p. 468-474 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Evolving Landscape of New Drug Approval in Japan and Lags f..:

Tanaka, Mototsugu ; Idei, Mayumi ; Sakaguchi, Hiroshi...
Clinical Pharmacology & Therapeutics.  109 (2020)  5 - p. 1265-1273 , 2020
Link: https://doi.org/10.1002/..
 
?
13

Health-related quality of life on combination therapy with ..:

Tanaka, Mototsugu ; Ishibashi, Yoshitaka ; Hamasaki, Yoshifumi...
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis.  40 (2020)  5 - p. 462-469 , 2020
Link: https://doi.org/10.1177/..
 
?
14

Mutational diversity in mutY deficient Helicobacter pylori ..:

Kinoshita-Daitoku, Ryo ; Kiga, Kotaro ; Sanada, Takahito...
Biochemical and Biophysical Research Communications.  525 (2020)  3 - p. 806-811 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Ultrafiltration volume by once‐weekly hemodialysis is a pre..:

Tanaka, Mototsugu ; Ishibashi, Yoshitaka ; Hamasaki, Yoshifumi...
Therapeutic Apheresis and Dialysis.  25 (2020)  1 - p. 82-87 , 2020
Link: https://doi.org/10.1111/..
 
1-15